Психические расстройства в общей медицине. №3 2013

Психические расстройства в практике невролога (обзор)

А.В.Андрющенко, Д.Ф.Пушкарев

ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России

Стр. 27-35

3460 просмотров

Опубликовано: 25 декабря 2013

Аннотация / Abstract

Резюме. В обзоре литературы приведены данные о бремени психических расстройств в неврологической практике, общей распространенности и распределении психических расстройств среди неврологических пациентов. Рассмотрены сложности классификации и диагностики психических расстройств в неврологической практике и возможные пути их решения. В качестве серьезной медицинской проблемы выделены неврологические заболевания (эпилепсия, болезнь Паркинсона, рассеянный склероз, инсульт головного мозга, болезнь Гентингтона), при которых коморбидные психические расстройства оказывают наиболее значимое негативное влияние на течение основного заболевания. Ключевые слова: эпилепсия, болезнь Паркинсона, рассеянный склероз, инсульт головного мозга, болезнь Гентингтона. Psychiatric disorders in neurological setting: a review A.V.Andryushchenko, D.F.Pushkarev I.M.Sechenov First Moscow State Medical University Summary. The paper reviews the data on the burden of psychiatric disorders in neurological setting, their prevalence and ratio. The differences of neurological and psychiatric approaches to brain disorders are considered along with ensuing conceptual and diagnostical difficulties. Finally the authors examine the clinical features and prevalence of psychiatric disorders comorbid to some important neurological diseases: epilepsy, Parkinson disease, multiple sclerosis, stroke, and Huntington disease. The data reviewed suggests necessity of the dialogue intensification between psychiatry and neurology, which are detached out of date. Key words: epilepsy, Parkinson disease, multiple sclerosis, stroke, and Huntington disease. Введение Современные клинические и эпидемиологические исследования, проведенные с использованием информативных баз данных и экспертных систем, показали актуальность изучения соотношения неврологических заболеваний и психических расстройств на основе интегративного подхода. Всестороннее взаимодействие – принципиальное требо...

Материал для специалистов

Полный текст статьи доступен только зарегистрированным пользователям.

Вход / Регистрация

1. Вейн А.М. и др. Болевые синдромы в неврологической практике. М.: МЕДпресс-информ, 2001.
2. Вейн А.М., Вознесенская Т.Г., Голубев В.Л., Дюкова Г.М. Депрессия в неврологической практике. М., 2002.
3. Вейн А.М., Дюкова Г.М., Воробьева О.В., Данилов А.В. Панические атаки. Руководство для врачей. М., 2004.
4. Дамиулин И.В. Сосудистые когнитивные нарушения: клинические и терапевтические аспекты. РМЖ. Неврология. Психиатрия. 2006; 14 (9): 658–64.
5. Штернберг Э.Я. Клиника деменций пресенильного возраста. М., 1967.
6. Яхно Н.Н., Захаров В.В., Нодель М.Р. Когнитивные и другие нервно-психические расстройства при болезни Паркинсона. Болезни движений: медицинские и социальные аспекты. Под ред. Е.И.Гусева, А.Б.Гехт. М., 2010; с. 95–102.
7. Bakshi R, Shaikh ZA, Miletich RS et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000; 6: 181–5.
8. Bridges K, Goldberg DP. Psychiatric illness in in-patients with neurological disorders: patients' views on discussion of emotional problems with neurologists. Br Med J 1984; 289: 656–8.
9. Burvill PW, Johnson GA, Jamrozik KD et al. Anxiety disorders after stroke: results from the perth community stroke study. Brit J Psychiat 1995; 166: 328–32.
10. Carson AJ, Postma K, Stone J et al. The outcome of depressive disorders in neurology patients: a prospective cohort study. J Neurol Neurosurg Psychiat 2003; 74: 893–6.
11. Carson AJ, Ringbauer B, Stone J et al. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiat 2000; 68: 207–10.
12. Di Legge S, Piattella MC, Pozzilli C et al. Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis. Mult Scler 2003; 9: 302–6.
13. Ehrt U, Bronnick K, Leentjens AF et al. Depressive symptom profile in Parkinson’s disease: a comparison with depression in elderly patients without Parkinson’s disease. Int J Geriat Psychiat 2006; 21 (3): 252–8.
14. Feinstein A, Feinstein K. Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Dis 2001; 66: 193–8.
15. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiat 2004; 49: 157–63.
16. Fink P, Hansen MS, Søndergaard L, Frydenberg M. Mental illness in new neurological patients. J Neurol Neurosurg Psychiat 2003; 74: 817–9.
17. Fink P, Steen Hansen M, Søndergaard L. Somatoform disorders among first-time referrals to a neurology service. Psychosom 2005; 46 (6): 540–8.
18. Fitzgerald P, Herlihy D, Sweeney B et al. Neurology referrals to a liaison psychiatry service. Ir Med J 2008; 101 (9): 271–3.
19. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Dis 2010; 25 (15): 2493–500.
20. Giordano A, Granella F, Lugaresi A et al. Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 2011; 307: 86–91.
21. Goldman consensus group. The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis 2005; 11: 328–37.
22. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology and treatment. Neurology 2002; 59 (Suppl. 4): s48–55.
23. Janssens AC JW, van Doorn PA, de Boer JB et al. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003; 108: 389–95.
24. Jefferies K, Owino A, Rickards H, Agrawal N. Psychiatric disorders in inpatients on a neurology ward: estimate of prevalence and usefulness of screening questionnaires J Neurol Neurosurg Psychiat 2007; 78: 414–6.
25. Kanner AM. Mood disorders and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neuroscience 2008; 10 (1): 39–47.
26. Kirk C, Saunders M. Primary psychiatric illness in a neurological out-patients department in North-East England. An analysis of symptomatology. Acta Psychiat Scand 1977; 56: 294–302.
27. Kirk C, Saunders M. Psychiatric illness in a neurological out-patients department in North-East England. Use of the General Health Questionnaire in the prospective study of neurological out-patients. Acta Psychiat Scand 1979; 60: 427–37.
28. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007; 13: 67–72.
29. Kurtzke JF. The current neurological burden of illness and injury in the United States. Neurology 1982; 32: 1207–14.
30. Leentjens AF, Dujardin K, Marsh L et al. Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Dis 2008; 23 (14): 2004–14.
31. Lyketsos C et al. Psychiatric aspects of neurologic diseases. NY, 2008.
32. Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler 2006; 12: 204–8.
33. Moller A, Wiedemann G, Rohde U et al. Correlates of Cognitive Impairment and Depressive Mood Disorder in Multiple Sclerosis. Acta Psychiat Scand 1994; 89: 117–21.
34. Naismith SL, Hickie IB, Lewis SJ. The role of mild depression in sleep disturbance and quality of life in Parkinson’s disease. J Neuropsychiat Clin Neurosci 2010; 22 (4): 384–9.
35. Donnchadha S, Burke T, Bramham J et al. Symptom overlap in anxiety and multiple sclerosis. Multiple Sclerosis J 2013; 19 (10): 1349–54.
36. Oguru M, Tachibana H, Toda K et al. Apathy and Depression in Parkinson Disease Journal of Geriatric Psychiatry and Neurolog 2010; 23 (1): 35–41.
37. Patten SB, Beck CA, Williams JV et al. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003; 61: 1524–7.
38. Patten SB, Metz LM. Depression in multiple sclerosis. Psychother Psychosom 1997; 66: 286–92.
39. Patten SB, Williams JV, Wang J. Mental disorders in a population sample with musculoskeletal disorders. BMC Musculoskelet Dis 2006; 7: 37.
40. Reijnders JS, Ehrt U, Weber WE et al. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Dis 2008; 23 (2): 183–9.
41. Rosenblatt A. Neuropsychiatry in Huntington’s disease. Dialogues Clin Neurosci 2007; 9: 191–7.
42. Sadovnik AD, Remick RA, Allen J et al. Depression and multiple sclerosis. Neurology 1996; 46: 628–32.
43. Schieffer RB, Rao SM, Fogel BS. Neuropsychiatry. 2nd ed. Philadelphia etc., 2003.
44. Schreurs KM, de Ridder DT, Bensing JM. Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. J Psychosom Res 2002; 53: 775–81.
45. Siegert R, Abernethy D. Depression in multiple sclerosis: a review.
J Neurol Neurosurg Psychiat 2005; 76: 469–75.
46. Slaughter JR, Slaughter KA, Nichols D et al. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s disease. J Neuropsychiat Clin Neurosci 2001; 13 (2): 187–96.
47. Smith SJ, Young CA. The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 2000; 14: 50–4.
48. Starkstein SE, Merello M, Jorge R et al. A validation study of depressive syndromes in Parkinson’s disease. Mov Dis 2008; 23 (4): 538–46.
49. Stone J, Carson A, Duncan R et al. Symptoms’ unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow up? Brain 2009; 132: 2878–88.
50. Suh Y, Motl RW, Mohr DC. Physical activity, disability, and mood in the early stage of multiple sclerosis. Disabil Health J 2010; 3: 93–8.
51. Tarrants M, Oleen-Burkey M, Castelli-Haley J, Lage MJ. The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis Multiple Sclerosis International 2011. ID271321.
52. Taylor MA. The Fundamentals of clinical neuropsychiatry. NY, Oxford 1999.
53. Tumas V, Rodrigues GG, Farias TL, Crippa JA. The accuracy of diagnosis of major depression in patients with Parkinson’s disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory. Arq Neuropsiquiat 2008; 66 (2A): 152–6.
54. Werf SP, Evers A, Jongen PJ et al. The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis. Mult Scler 2003; 9: 89–94.
55. Visser M, Rooden SM, Verbaan D et al. A comprehensive model of health-related quality of life in Parkinson’s disease. J Neurol 2008; 255 (10): 1580–7.
56. Wallin MT, Wilken JA, Turner AP et al. Depression and multiple sclerosis. Review of a lethal combination. J Rehabil Res Dev 2006; 43: 45–62.
57. Williams LS, Jones WJ, Shen J et al. Prevalence and impact of depression and pain in neurology outpatients J Neurol Neurosurg Psychiat 2003; 74: 1587–9.
58. Wood B, Mei IA, Ponsonby A-L et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Multiple Sclerosis J 2012; 19 (2): 217–24.
59. Zahodne LB, Marsiske M, Okun MS, Bowers D. Components of depression in Parkinson disease. J Geriat Psychiat Neurol 2012; 25 (3): 131–7.

ЖУРНАЛЫ

ИНТЕРАКТИВ

СПЕЦИАЛИЗАЦИИ

ИЗДАНИЯ-ПАРТНЕРЫ

Психические расстройства в практике невролога (обзор)

Материал для специалистов

ЖУРНАЛЫ

ИНТЕРАКТИВ

СПЕЦИАЛИЗАЦИИ

ИЗДАНИЯ-ПАРТНЕРЫ

Психические расстройства в практике невролога (обзор)

Материал для специалистов

Con-Med Passport